Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
There are no standard neodjuvant regimens adapted according to the different subtypes of
breast cancer. This is a phase 2, randomized study to evaluate several regimens in different
subtypes of breast cancer.